Publications by authors named "Eike Gallmeier"

Claim this Profile
S
Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy.
Hanna Elisabeth Schneider, Lisa-Maria Schmitt, Albert Job, Brigitte Lankat-Buttgereit, Thomas Gress, Eike Gallmeier

Neoplasia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
Thomas J Ettrich, Dominik P Modest, Marianne Sinn, Jana K Striefler, Bernhard Opitz, Eike Gallmeier

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Salah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, Claudia Pauligk, Caroline Schönherr, Eike Gallmeier

Int J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The POLD1 variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors.
Albert Job, Marina Tatura, Cora Schäfer, Veronika Lutz, Hanna Schneider, Eike Gallmeier

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional evaluation of variants of unknown significance in the BRCA2 gene identified in genetic testing.
Marie Heczkova, Eva Machackova, Peter Macinga, Eike Gallmeier, Monika Cahova

Cancer Biol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer.
Andreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, Waldemar Uhl, Hana Algül, Eike Gallmeier

Theranostics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
Thomas J Ettrich, Andreas W Berger, Lukas Perkhofer, Severin Daum, Alexander König, Eike Gallmeier

BMC Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors.
Albert Job, Lisa-Maria Schmitt, Lisa von Wenserski, Brigitte Lankat-Buttgereit, Thomas M Gress, Eike Gallmeier

Neoplasia· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Stephan Kruger, Michael Haas, Carolin Burkl, Peter Goehring, Axel Kleespies, Eike Gallmeier

Thromb Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Elise Punkenburg, Tina Vogler, Maike Büttner, Kerstin Amann, Max Waldner, Eike Gallmeier

Gut· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.
Dominique Harnicek, Eric Kampmann, Kirsten Lauber, Roman Hennel, Ana Sofia Cardoso Martins, Eike Gallmeier

Int J Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.
Sandra Hocke, Yang Guo, Albert Job, Michael Orth, Andreas Ziesch, Eike Gallmeier

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.
Enrico N De Toni, Andreas Ziesch, Antonia Rizzani, Helga-Paula Török, Sandra Hocke, Eike Gallmeier

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversy on the time to progression of pancreatic ductal adenocarcinoma.
Eike Gallmeier, Ruben Hernaez, Thomas M Gress

Gut· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1.
Shuai Lu, Helga-Paula Török, Eike Gallmeier, Frank T Kolligs, Antonia Rizzani

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Eike Gallmeier

J Cell Mol Med· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK expression is absent in pancreatic ductal adenocarcinoma.
Steffen Ormanns, Gerald Assmann, Simone Reu, Eike Gallmeier, Dominik C Bader

J Cancer Res Clin Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.
Benjamin Hirschi, Eike Gallmeier, Andreas Ziesch, Maximilian Marschall, Frank T Kolligs

Mol Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
Eike Gallmeier, Dominik C Bader, Lydia Kriegl, Sabina Berezowska, Hendrik Seeliger

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
Lydia Kriegl, Andreas Jung, David Horst, Antonia Rizzani, Rene Jackstadt, Eike Gallmeier

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
Claus Schäfer, Hendrik Seeliger, Dominik C Bader, Gerald Assmann, Denise Buchner, Eike Gallmeier

J Cell Mol Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-enhanced ultrasound for surveillance of choroidal carcinoma patients: features of liver metastasis arising several years after treatment of the primary tumor.
Enrico N De Toni, Eike Gallmeier, Christoph J Auernhammer, Dirk-Andrè Clevert

Case Rep Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.
Eike Gallmeier, Patrick C Hermann, Maria-Theresa Mueller, Juan G Machado, Andreas Ziesch

Stem Cells· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma.
Lydia Kriegl, Andreas Jung, Jutta Engel, Rene Jackstadt, Alexander L Gerbes, Eike Gallmeier

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old.
Steven C Cunningham, Eike Gallmeier, Scott E Kern

Aging (Albany NY)· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis